There have been 50 recent insider transactions recorded for Voyager Therapeutics, Inc. (VYGR), including 23 buys and 26 sells. Total insider buying was valued at $8.02M and total insider selling at $799.58K.
Notable insiders with recent activity include Sandrock Alfred, Shiferman Gregory L., Jorgensen Nathan D.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — VYGR
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-02 |
Sandrock Alfred |
President and CEO |
Informative Sell |
11,511 |
$3.87 |
$44.55K |
472,549 |
| 2026-04-01 |
Shiferman Gregory L. |
SVP and General Counsel |
RSU Award |
50,000 |
- |
- |
50,000 |
| 2026-02-24 |
Sandrock Alfred |
President and CEO |
Informative Sell |
14,197 |
$3.79 |
$53.81K |
484,060 |
| 2026-02-24 |
Jorgensen Nathan D. |
Chief Financial Officer |
Informative Sell |
4,668 |
$3.77 |
$17.6K |
151,416 |
| 2026-02-24 |
Swartz Robin |
COO & Cbo |
Informative Sell |
6,458 |
$3.77 |
$24.35K |
199,738 |
| 2026-02-24 |
Carter Todd Alfred |
Chief Scientific Officer |
Informative Sell |
4,174 |
$3.76 |
$15.69K |
145,718 |
| 2026-02-18 |
Sandrock Alfred |
President and CEO |
Informative Sell |
11,732 |
$3.41 |
$40.01K |
498,257 |
| 2026-02-18 |
Swartz Robin |
COO & Cbo |
Informative Sell |
3,882 |
$3.44 |
$13.35K |
206,196 |
| 2026-02-18 |
Carter Todd Alfred |
Chief Scientific Officer |
Informative Sell |
3,301 |
$3.44 |
$11.36K |
149,892 |
| 2026-02-10 |
Sandrock Alfred |
President and CEO |
Informative Sell |
12,192 |
$3.78 |
$46.09K |
509,989 |
| 2026-02-10 |
Swartz Robin |
COO & Cbo |
Informative Sell |
4,569 |
$3.85 |
$17.59K |
210,078 |
| 2026-02-10 |
Carter Todd Alfred |
Chief Scientific Officer |
Informative Sell |
3,525 |
$3.85 |
$13.57K |
153,193 |
| 2026-02-06 |
Sandrock Alfred |
President and CEO |
RSU Award |
402,500 |
$3.68 |
$1.48M |
402,500 |
| 2026-02-06 |
Jorgensen Nathan D. |
Chief Financial Officer |
RSU Award |
150,500 |
$3.68 |
$553.84K |
150,500 |
| 2026-02-06 |
Swartz Robin |
COO & Cbo |
RSU Award |
210,000 |
$3.68 |
$772.8K |
210,000 |
| 2026-02-06 |
Carter Todd Alfred |
Chief Scientific Officer |
RSU Award |
154,000 |
$3.68 |
$566.72K |
154,000 |
| 2026-02-06 |
Ferguson Toby |
Chief Medical Officer |
RSU Award |
45,000 |
- |
- |
183,914 |
| 2026-01-06 |
Shiferman Gregory L. |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-01-06 |
Shiferman Gregory L. |
SVP and General Counsel |
RSU Award |
100,000 |
$4.02 |
$402K |
100,000 |
| 2025-10-03 |
Jorgensen Nathan D. |
Chief Financial Officer |
Informative Sell |
7,666 |
$4.78 |
$36.64K |
123,834 |
| 2025-08-18 |
Ferguson Toby |
Chief Medical Officer |
Informative Sell |
19,000 |
$3.73 |
$70.87K |
138,914 |
| 2025-06-03 |
Scangos George A |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Geraghty James A |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Pierce Glenn |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Higgins Michael J |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Mackey Catherine J |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Hyman Steven |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Colon Grace |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Vitale Nancy |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-06-03 |
Onyia Jude |
Director |
RSU Award |
24,000 |
$3.28 |
$78.72K |
24,000 |
| 2025-04-02 |
Sandrock Alfred |
President and CEO |
Informative Sell |
10,885 |
$3.43 |
$37.34K |
430,931 |
| 2025-04-02 |
Ferguson Toby |
Chief Medical Officer |
Informative Sell |
10,086 |
$3.43 |
$34.59K |
157,914 |
| 2025-02-21 |
Sandrock Alfred |
President and CEO |
RSU Award |
290,000 |
$4.22 |
$1.22M |
290,000 |
| 2025-02-21 |
Jorgensen Nathan D. |
Chief Financial Officer |
RSU Award |
103,000 |
$4.22 |
$434.66K |
103,000 |
| 2025-02-21 |
Swartz Robin |
COO & Cbo |
RSU Award |
142,500 |
$4.22 |
$601.35K |
142,500 |
| 2025-02-21 |
Carter Todd Alfred |
Chief Scientific Officer |
RSU Award |
92,000 |
$4.22 |
$388.24K |
92,000 |
| 2025-02-21 |
Fahey Sandell Jacquelyn |
Chief Legal Officer |
RSU Award |
83,000 |
$4.22 |
$350.26K |
83,000 |
| 2025-02-21 |
Ferguson Toby |
Chief Medical Officer |
RSU Award |
126,000 |
$4.22 |
$531.72K |
126,000 |
| 2025-02-20 |
Sandrock Alfred |
President and CEO |
Informative Sell |
11,702 |
$4.24 |
$49.62K |
296,816 |
| 2025-02-20 |
Swartz Robin |
COO & Cbo |
Informative Sell |
3,894 |
$4.25 |
$16.55K |
98,397 |
| 2025-02-20 |
Carter Todd Alfred |
Chief Scientific Officer |
Informative Sell |
3,305 |
$4.26 |
$14.08K |
77,718 |
| 2025-02-11 |
Sandrock Alfred |
President & CEO |
Informative Sell |
16,644 |
$4.45 |
$74.07K |
308,518 |
| 2025-02-11 |
Swartz Robin |
COO & Cbo |
Informative Sell |
6,950 |
$4.45 |
$30.93K |
102,291 |
| 2025-02-11 |
Carter Todd Alfred |
Chief Scientific Officer |
Informative Sell |
5,413 |
$4.45 |
$24.09K |
81,023 |
| 2025-02-11 |
Fahey Sandell Jacquelyn |
Chief Legal Officer |
Informative Sell |
4,358 |
$4.45 |
$19.39K |
81,643 |
| 2025-01-14 |
Swartz Robin |
COO & Cbo |
Informative Sell |
3,087 |
$5.09 |
$15.71K |
109,241 |
| 2025-01-14 |
Carter Todd Alfred |
Chief Scientific Officer |
Informative Sell |
1,191 |
$5.13 |
$6.11K |
86,436 |
| 2024-12-23 |
Swartz Robin |
COO&cbo |
Informative Sell |
6,500 |
$5.65 |
$36.73K |
112,328 |
| 2024-10-02 |
Fahey Sandell Jacquelyn |
Chief Legal Officer |
Informative Sell |
5,999 |
$5.82 |
$34.91K |
86,001 |
| 2024-10-01 |
Jorgensen Nathan D. |
Chief Financial Officer |
RSU Award |
80,000 |
- |
- |
80,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
